
Hagop Kantarjian/mdanderson.org
Aug 2, 2025, 08:58
Hagop Kantarjian: Advances and Revolution in Adult ALL Therapy Over the Last Decade
Hagop Kantarjian, Associate Vice President for Global Academic Programs at MD Anderson Cancer Center, shared a recent article he and his colleagues co-authored on X, adding:
“There have been major advances in ALL therapy over the last decade.
Check out our review just published in the ACS Journal discussing these advances and revolution in adult ALL therapy.”
Title: The evolving therapeutic revolution in adult acute lymphoblastic leukemia
Journal: ACS
Authors: Hagop Kantarjian, Nitin Jain, Mark R. Litzow, Selina M. Luger, Cristina Papayannidis, Josep-Maria Ribera, Nicholas J. Short, Helen T. Chifotides, Elias Jabbour
More posts featuring Hagop Kantarjian on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 2, 2025, 08:55
Aug 2, 2025, 08:54
Aug 2, 2025, 08:32
Aug 2, 2025, 08:07
Aug 2, 2025, 06:54
Aug 2, 2025, 06:37